Advancing Gene and Cell Therapies in South Africa

June 29, 2021 | 3 - 6:25 p.m. SAST

The goal of the symposium is for US and South African speakers with experience in clinical development to share their experiences and insights on factors to consider to successfully initiate clinical trials of gene and cell therapies in South Africa. Stimulating such additional clinical research is an important step in expanding availability and access to these therapies for patients in need in the area. Tentative agenda below:

Developing Gene Therapy Clinical Trials for Monogenic Diseases 

  • Gene Transfer for Genetic Diseases 
  • Increasing Transportability of Gene Therapies for Sickle Cell Disease 

Cell Therapies 

  • Getting Cell Therapy for Leukemia into Clinical Trials in South Africa: Challenges and Opportunities 
  • Considerations for Developing Genetically Modified T-cell Therapy Trials 

Regulatory Considerations for Early Gene Therapy Trials 

  • Regulatory Environment in South Africa 
  • Regulatory Considerations for Gene Therapy Trials in South Africa 





ASGCT 24th Annual Meeting

May 11-14, 2021

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.